Tech Nation + BioTech Nation + Global BioEntrepreneurship
Weekly Public Radio Program & Podcast
Episode 26-35 Air Date: September 1, 2026
On this week’s Tech Nation, Moira speaks with Katie Prescott, author of “The Curious Case of Mike Lynch”, about a titan of the Tech world, who lost his life along with his daughter and others when his luxury yacht tragically sank off the coast of Sicily. What happened leading up to that day, and is there more to the story? Then, you may have heard of peptides, but what exactly are they? Dr. Karsten Eastman of Sethera Therapeutics explains how they work, and how Sethera plans to develop enhanced peptides to create new medicines, starting with triple-negative breast cancer.
Episode 26-34Air Date: August 25, 2026
On this week’s Tech Nation, Moira speaks with Dr. Martin Borch Jensen and Dr. Francisco LePort from Gordian Biotechnology, who are working on diseases of aging before they even appear. Then, Tech Nation Health Chief Correspondent, Dr. Daniel Kraft, explains why mobility is the new vital sign. And Erica Dhawan, Author of Digital Body Language, tells us how to navigate the misinterpretations of digital communication.
Episode 26-33 Air Date: August 18, 2026
On this week’s Tech Nation, Moira speaks with Stanford University Research Scholar Adrienne Mayor, to discuss what ancient myths tell us about the deep history of planet earth in her book "Mythopedia". Then in biotech, Dr. Ned Swanson, President and Chief Medical Officer of Polarity Bio, tells us about their approach to healing serious, hard-to-treat skin wounds. In early trials, it’s twice as effective as the current treatment for diabetic foot ulcers.
BioTech Nation PODCASTS
September 1, 2026
Dr. Karsten Eastman Co-Founder & CEO Sethera Therapeutics
  • You've probably heard of Peptides...but what exactly are they? And how do we know which ones are effective, and safe? Dr. Karsten Eastman, Co-Founder and CEO of Sethera Therapeutics, joins to answer all our questions about Peptides, and to tell us about Sethera's latest efforts to enhance peptides to make new medicines. Their plan: to develop a drug using enhanced peptides for Triple-Negative Breast Cancer... and they've already received funding.

August 25, 2026

Sameer Sabir Co-Founder & CEO, Brixton Biosciences

This week on BioTech Nation, Sameer Sabir, CEO of Brixton Biosciences, shares how their breakthrough injectable cold therapy, Neural Ice, could offer lasting relief for osteoarthritis pain. With a drug-free, nerve-targeting approach currently in clinical trials, this innovation may change how we treat joint pain without pills or repeated steroid injections.
The J.P. Morgan Healthcare Conference 2026
5 Companies Ready to Make A Difference
In San Francisco, biotech entrepreneurs, innovators, and investors from all over the globe are gathering at the 44th Annual J.P. Morgan Healthcare Conference. To coincide with the conference, we’ve put together a special release of 5 BioTech Nation interviews…
These are the JP Morgan Conference 2026 BioTech Nation “5”!
We hear from 5 unique BioTech companies ready to make a difference. Hear their stories directly from the founders, CEOs, and scientists that are making waves in the biotech world:
💡 A New Way to Treat Cancer - Cyriac Roeding & Dr. David Suhy, Earli
💡 A Speedy Intervention for Heart Attacks - Dr. Harry Selker & Atul Deshpande Ph.D., MBA, A-PMP, IMMEDIATE Therapeutics
💡 A Fast-Acting Dupixent? - Dr. Barry Quart, Connect Biopharma
💡 You’ve Had Back Pain for 7-10 Years?- Neil Klompas, Augurex Life Sciences Corp.
💡 A Euphoria-Suppressing Opioid - Ketan Mehta, Tris Pharma
Industry Insights. Startup Directory. Academic Journal. More Information coming soon.